Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$131.14 - $157.47 $2,622 - $3,149
-20 Reduced 50.0%
20 $3,000
Q1 2022

May 04, 2022

SELL
$181.39 - $234.03 $167,060 - $215,541
-921 Reduced 95.84%
40 $8,000
Q4 2021

Feb 10, 2022

BUY
$193.69 - $247.03 $120,281 - $153,405
621 Added 182.65%
961 $235,000
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $24,607 - $27,259
-130 Reduced 27.66%
340 $66,000
Q2 2021

Aug 11, 2021

BUY
$155.9 - $187.99 $73,273 - $88,355
470 New
470 $88,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Portfolio

Follow Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Morgan Stanley Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. with notifications on news.